Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
236
236 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- AMT-162Phase 21 trial
UniQure Biopharma B.V. · Amyotrophic Lateral Sclerosis
- AP-101Phase 21 trial
AL-S Pharma · Amyotrophic Lateral Sclerosis
- AP-472Phase 21 trial
Appello Pharmaceuticals, Inc. · Parkinson Disease
- ARGX-119Phase 21 trial
argenx · Spinal Muscular Atrophy (SMA)
- AritinerceptPhase 21 trial
Aurinia Pharmaceuticals Inc. · Myasthenia Gravis, Generalized
- ATR 1072Phase 21 trial
Atrium Therapeutics · Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic
- AV078Phase 21 trial
Aeovian Pharmaceuticals, Inc. · Tuberous Sclerosis Complex, Epilepsy
- BEY2153Phase 21 trial
BeyondBio Inc. · Alzheimer Disease, Alzheimer' Disease
- BHV-2100Phase 21 trial
Biohaven Therapeutics Ltd. · Migraine
- BIA 28-6156Phase 21 trial
Bial R&D Investments, S.A. · Parkinson's Disease
- BIIB091Phase 21 trial
Biogen · Relapsing Forms of Multiple Sclerosis
- BIIB147Phase 21 trial
Biogen · Amyotrophic Lateral Sclerosis
- BMS-986446Phase 21 trial
Bristol Myers Squibb · Alzheimer Disease, Early Onset
- BXQ-350SapC-DOPSPhase 21 trial
Bexion Pharmaceuticals, Inc. · Metastatic Colorectal Carcinoma, Neuropathy
- CB03-154Phase 21 trial
Shanghai Zhimeng Biopharma, Inc. · Focal Epilepsy
- CNP-106Phase 21 trial
COUR Pharmaceutical Development Company, Inc. · Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis
- CORT113176DazucorilantPhase 21 trial
Corcept Therapeutics · Amyotrophic Lateral Sclerosis
- CPL500036Phase 21 trial
Celon Pharma SA · Parkinson Disease, Dyskinesia, Medication-Induced
- DiranersenISIS 814907, BIIB080Phase 21 trial
Biogen · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia
- DT-216P2Phase 21 trial
Design Therapeutics, Inc. · Friedreich Ataxia
- E2086Phase 21 trial
Eisai · Narcolepsy
- E2814Phase 21 trial
Eisai · Alzheimer's Disease
- EC5026Phase 21 trial
EicOsis Human Health Inc. · Parkinson's Disease (PD)
- EI-1071Phase 21 trial
Elixiron Immunotherapeutics Inc. · Mild, Moderate, or Severe Alzheimer's Disease
- ER2001Phase 21 trial
ExoRNA Bioscience · Huntington Disease
- EX039Phase 21 trial
Excelsior · Alzheimer Disease
- exidavnemabPhase 21 trial
BioArctic AB · Parkinson Disease, Multiple System Atrophy
- FHND1002Phase 21 trial
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · Amyotrophic Lateral Sclerosis (ALS)
- ForalumabPhase 21 trial
Tiziana Life Sciences LTD · Secondary Progressive Multiple Sclerosis
- GB221Phase 21 trial
Gemma Biotherapeutics · Spinal Muscular Atrophy Type I
- GSK4527226Phase 21 trial
GSK · Alzheimer's Disease
- GT-02287GT-02287 400, GT-02287 800Phase 21 trial
Gain Therapeutics, Inc. · Parkinson Disease
- HT-4253Phase 21 trial
Halia Therapeutics, Inc. · Alzheimers Disease
- IRL757Phase 21 trial
Integrative Research Laboratories AB · PARKINSON DISEASE (Disorder), Apathy, Safety
- IVL3003Phase 21 trial
Inventage Lab., Inc. · Alzheimer Disease
- JNJ-64042056Phase 21 trial
Johnson & Johnson (Janssen) · Alzheimer Disease
- KDT-3594Phase 21 trial
Kissei Pharmaceutical Co., Ltd. · Parkinson Disease
- LHP588Phase 21 trial
Lighthouse Pharmaceuticals, Inc. · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
- LTX-002Phase 21 trial
Leal Therapeutics, Inc · Amyotrophic Lateral Sclerosis
- LY03015LPM3770164 sustained releasePhase 21 trial
Luye Pharma Group Ltd. · Tardive Dyskinesia (TD)
- LY3848575Phase 21 trial
Eli Lilly · Neuropathic Pain, Distal Sensory Polyneuropathy
- LY3884961Phase 21 trial
Prevail Therapeutics · Parkinson Disease
- MBF-015Phase 21 trial
Medibiofarma S.L. · Huntington Disease
- MEDI0618Phase 21 trial
AbbVie · Migraine
- MK-2214Phase 21 trial
Merck & Co. · Early Alzheimer's Disease
- MT101-5Phase 21 trial
Mthera Pharma Co., Ltd. · Parkinson's Disease
- MTX101Phase 21 trial
Manistee Therapeutics · Migraine
- NB-4746Phase 21 trial
Nura Bio · Amyotrophic Lateral Sclerosis (ALS)
- NBI-1065890Phase 21 trial
Neurocrine Biosciences · Tardive Dyskinesia
- NBI-1117567Phase 21 trial
Neurocrine Biosciences · Alzheimer's Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.